Patent classifications
A61L2430/30
PROSTHETIC REPAIR SYSTEM AND METHOD OF USE
A prosthetic repair system includes a prosthesis for repairing a defect in a tissue or muscle wall. A material delivery device is provided for delivering a material, such as an adhesive material, to a surface of the prosthesis and/or to particular locations between the prosthesis and the tissue or muscle wall to attach the prosthesis to the wall. The delivery device may be coupled to the prosthesis and configured to distribute the material from one side of the prosthesis to an opposite side that is to face the defect. The delivery device may include a manifold and conduits for delivering the material from the manifold to one or more desired locations. The conduits may penetrate into and/or through the thickness of the prosthesis. After delivery and distribution of the material, the delivery device may be removed from the prosthesis and withdrawn from) a patient.
A THREE-DIMENSIONAL TISSUE SCAFFOLD WITH STEM CELL ATTRACTING ELEMENT AND USE THEREOF
Provided is a three dimensional tissue scaffold comprising a stem cell attracting element associated with a matrix, and fusion protein of stem cell attracting factor and collagen-binding domain, and methods of uses thereof.
DEVICES INCLUDING MUSCLE MATRIX AND METHODS OF PRODUCTION AND USE
Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.
VASCULAR CAST-BASED SCAFFOLDS AND METHODS OF MAKING THE SAME
The present application relates to biomimetic three-dimensional (3D) scaffolds, constructs and methods of making the same. The three-dimensional scaffold can include a sacrificial internal cast and a durable external scaffold material, wherein the durable external scaffold material comprises a biocompatible material which completely surrounds the sacrificial internal cast and wherein the sacrificial internal cast be removed to yield a branching 3D network of hollow, vessel-like tubes that substantially mimics a native tissue or organ.
MUSCLE TISSUE REGENERATION USING MUSCLE FIBER FRAGMENTS
The invention is directed to methods and compositions for obtaining uniform sized muscle fiber fragments for transplantation. These muscle fiber fragments are able to reconstitute into long fibers that are oriented along native muscle. The implanted muscle cells integrate with native vascular and neural network, as confirmed by histology and immunohistochemistry. This invention is particularly advantageous because autologous muscle can be harvested from a donor site, processed and injected into target sites in the operating room. The fragmented muscle fibers can be readily integrated within the host.
MULTIAXIAL ARTIFICIAL MUSCLE TISSUE, AND METHOD AND STRUCTURE FOR FORMING SAME
A multiaxial artificial muscle tissue is provided. The multiaxial artificial muscle tissue according to an embodiment of the present invention is a multiaxial artificial muscle tissue contractible or stretchable about a plurality of axes and comprises: a first module formed by gelling a hydrogel including muscle cells and extending in a first axial direction so as to be contractible or stretchable in the first axial direction; and a second module formed by gelling the hydrogel and extending in a second axial direction to be contractible or stretchable in the second axial direction, wherein a portion of the hydrogel and a portion of the hydrogel which constitute the first module and the second module, respectively, are integrated with each other such that a portion of the first module and a portion of the second module are connected to each other.
Methods, substrates, and systems useful for cell seeding of medical grafts
Described are methods, cell growth substrates, and devices that are useful in preparing cell-containing graft materials for administration to patients. Tubular passages can be defined in cell growth substrates to promote distribution of cells into the substrates. Also described are methods and devices for preparing cell-seeded graft compositions, methods and devices for preconditioning cell growth substrates prior to application of cells, and cell seeded grafts having novel substrates, and uses thereof.
Connective-tissue-based or dermal-tissue-based grafts/implants
The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.
Compositions for Regenerating Defective or Absent Myocardium
Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.
Innervation of engineered structures
Methods of generating an innervated muscle structures are disclosed as well as bioengineered structures for tissue repair or regeneration. The methods can include the steps of obtaining populations of smooth muscle cells and neuronal progenitor cells and then seeding the cells together onto a matrix material, followed by culturing the seeded cells to form an innervated smooth muscle cell construct of directionally oriented smooth muscle cells. In one embodiment, the neuronal progenitor cells can be seeded first as neurospheres in a biocompatible solution, e.g., a collagen/laminin solution, and allowed to gel. Next, a second suspension of smooth muscle cells can be deposited as separate layer. Multiple layer structures of alternating muscle or neuron composition can also be formed in this manner. Differentiation of the neuronal progenitor cells can be induced by exposure to a differentiation medium, such as Neurobasal A medium and/or exposure to a differentiating agent, such as B-27 supplement. The innervated muscle structures can be disposed around a tubular scaffold, e.g., a chitosan-containing tube and further cultured to form tubular, bioengineered structures and two or more innervated muscle structures can be joined together to form an elongate composite structure.